Literature DB >> 16729958

A comparison of methods for the analysis of low abundance proteins in desmoid tumor cells.

L Picariello1, S Carbonell Sala, V Martineti, A Gozzini, P Aragona, I Tognarini, M Paglierani, G Nesi, M L Brandi, F Tonelli.   

Abstract

The desmoids are a group of rare clinically diverse, deep-seated fibrous neoplasms. The exact etiology is unknown, but several factors are considered to be positively correlated with their development and growth, i.e., genetic and hormonal factors and trauma. These tumors may be sporadic or associated with a genetic disease such as familial adenomatous polyposis (FAP). Devoid of metastatic potential, they tend to form large, infiltrative masses which, if not completely excised, recur repeatedly. Although surgery is widely accepted as the first-line treatment for extra-abdominal and abdominal wall desmoids, a proportion of cases are successfully palliated with either estrogen antagonists (tamoxifen, toremifene, and raloxifene) or nonsteroidal anti-inflammatory drugs. We describe and compare four methods for evaluating the expression of estrogen receptors alpha/beta and COX-1 and COX-2 in desmoid tumor-derived cells and tissues: immunocytochemistry, immunohistochemistry, RT-PCR, and two-color Western blot detection with the Odyssey infrared imaging system. Through this comparative analysis, Western blot with Odyssey was recognized as the best method to analyze the expression particularly of low expressed proteins in desmoid-derived cells. The use of a specific and reliable assessment method becomes fundamental in the evaluation of the presence and modulation of proteins which are important but weakly expressed in these rare tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16729958     DOI: 10.1016/j.ab.2006.03.047

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  7 in total

1.  Disruption of p73-MDM2 binding synergizes with gemcitabine to induce apoptosis in HuCCT1 cholangiocarcinoma cell line with p53 mutation.

Authors:  Tongsen Zheng; Jiabei Wang; Xi Chen; Xianzhi Meng; Xuan Song; Zhaoyang Lu; Hongchi Jiang; Lianxin Liu
Journal:  Tumour Biol       Date:  2010-04-27

2.  Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptors.

Authors:  Nicholas A Mignemi; Doha M Itani; John H Fasig; Vicki L Keedy; Kenneth R Hande; Brent W Whited; Kelly C Homlar; Hernan Correa; Cheryl M Coffin; Jennifer O Black; Yajun Yi; Jennifer L Halpern; Ginger E Holt; Herbert S Schwartz; Jonathan G Schoenecker; Justin M M Cates
Journal:  Cancer Sci       Date:  2012-11-15       Impact factor: 6.716

3.  Viability assays for cells in culture.

Authors:  Jessica M Posimo; Ajay S Unnithan; Amanda M Gleixner; Hailey J Choi; Yiran Jiang; Sree H Pulugulla; Rehana K Leak
Journal:  J Vis Exp       Date:  2014-01-20       Impact factor: 1.355

4.  Quantitative proteomics analysis of the nuclear fraction of human CD4+ cells in the early phases of IL-4-induced Th2 differentiation.

Authors:  Robert Moulder; Tapio Lönnberg; Laura L Elo; Jan-Jonas Filén; Eeva Rainio; Garry Corthals; Matej Oresic; Tuula A Nyman; Tero Aittokallio; Riitta Lahesmaa
Journal:  Mol Cell Proteomics       Date:  2010-05-13       Impact factor: 5.911

5.  Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells.

Authors:  Monica Guidi; Margarita Muiños-Gimeno; Birgit Kagerbauer; Eulàlia Martí; Xavier Estivill; Yolanda Espinosa-Parrilla
Journal:  BMC Mol Biol       Date:  2010-12-10       Impact factor: 2.946

6.  A quasi-quantitative dual multiplexed immunoblot method to simultaneously analyze ATM and H2AX Phosphorylation in human peripheral blood mononuclear cells.

Authors:  Christopher J Bakkenist; R Kenneth Czambel; Pamela A Hershberger; Hussein Tawbi; Jan H Beumer; John C Schmitz
Journal:  Oncoscience       Date:  2015-05-14

Review 7.  Misdiagnosis of aggressive fibromatosis of the abdominal wall: A case report and literature review.

Authors:  Xiaoxia Liu; Shan Zong; Yingli Cui; Ying Yue
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.